antibody-dependent complement-mediated or antibody-ricin-mediated destruction of cells expressing cell-surface marker; and (5) antibodymediated blockade of cell-surface marker.
Over the last few years it has been demonstrated that antibodies recognizing a variety of neurotransmitter biosynthetic enzymes { i.e. choline acetyltransferase (ChAT) [9, lysing, in the presence of complement, neurotransmitter-specific synaptosomal subpopulations (ie. cholinergic, GABAergic, dopaminergic, noradrenergic and serotonergic, respectively). Results obtained are summarized in Table 1 . Specific immunolysis usually results in a reduction in high-affinity transAbbreviations used: ChAT. choline acetyltransferase; GAD, glutamate decarboxylase; GABA, y-aminobutyric acid; LDH, lactate dehydrogenase; NRP, neurotransmitter-related protein; DRF, detergent-rich fraction; DPM, detergent-poor fraction; SPM, synaptic plasma membrane. port of neurotransmitter or its precursor and a release of soluble cytoplasmic contents. The release of lactate dehydrogenase (LDH), a general cytoplasmic marker, gives a measure of subpopulation size, assuming maximal lysis has been achieved and that all nerve terminals contain the same LDH concentration.
It has also been possible to immunoafinity purify synaptosomal subpopulations with these antibodies using an immunomagnetophoretic procedure [ 14-16]. This involves incubating antibody-labelled synaptosomes with magnetic beads (Magnogel, IBF) to which Protein A has been covalently bound. After sedimentation in a magnetic field and appropriate washing, antibody-labelled synaptosomes are retrieved on the magnetic beads (see Table 2 for summary of results). A high level of purification was achieved (based on increase in neurotransmitter synthesizing enzyme/LDH ratio) and varied from 2.5-fold (for GABAergic) to 10-fold (for cholinergic). The greater purification value achieved for the cholinergic compared to the GABAergic subpopulation reflects the lower number of cholinergic terminals in rat brain cortical synaptosome preparations.
These findings have led to a working hypothesis that neurons express specific neurotransmitter-related proteins (NRPs) on their cell-surface that are related to the neurotransmitter-synthesizing enzymes which they contain. What is the nature of these cell-surface molecules and why do antibodies raised to soluble cytoplasmic enzymes cross-react with them? There are at least four possibilities: (1) a form of the biosynthetic enzyme is present in the outer plasma membrane; (2) a cross-reacting peptide sequence is present in the membrane; (3) the plasma membrane contains unknown molecules (with no sequence homology to the enzymes) which are recognized by anti-idiotypic antibodies; and (4) the plasma membrane contains unknown molecules Table I lmmunolysis of synaptosomal subpopulations This is a summary of results obtained in several studies (see text for references). Synaptosomes were prepared from either the cerebral cortex (t) or corpus striatum (*) of rat brain and incubated in Krebs buffer with guinea-pig complement and the antibody under study (I ml final incubation volume). After 30 min at 37°C synaptosomes were pelleted at IOOOO g for 30 s. Pellets were washed by resuspension in fresh Krebs solution and enzyme activities measured after addition of Triton X-100. Triton was not added to supernatants before assay. Non-specific release was measured in synaptosome incubations when no complement or antibody was present, and when either complement or antibody acted alone. This release was never greater than 5-10% of the total content. Release was calculated after subtraction of non-specific release, as the percentage of the total (pellet plus supernatant) content. Recovery of activity was checked by comparison with unincubated controls. n.d., not determined; TH, tyrosine hydroxylase; DBH, dopamine b-hydroxylase; TPH, tryptophan hydroxylase; DA, dopamine; 5-HT, 5-hydroxytryptamine; NA, noradrenaline.
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(a) Reduction in high-affinity uptake of neurotransmitter or precursor % of control high-affinity uptake of 3H-ligand Nervous System Membrane Proteins Table 2 Synaptosomal subpopulations This is a summary of results from several studies (see text for details). Synaptosomes, prepared from the cerebral cortex (t) or corpus striatum (*) of rat brain were incubated at 4°C with either anti-ChAT (cholinergic), anti-GAD (GABAergic), anti-DBH (noradrenergic), anti-TH (dopaminergic) or anti-TPH (serotonergic). After washing to remove unbound antibody, labelled synaptosomes were incubated with Magnogel-Protein A. Synaptosomal subpopulations were isolated by exposure to a magnetic field, and washed by resuspension and sedimentation in this field. Synaptosomal contents were assayed usually after addi- capable of forming tertiary structures similar to those transiently formed by the biosynthetic enzymes during the synthesis of neurotransmitter.
What neurotransmitter-related cell-surface proteins are likely targets of these antibodies? The molecules recognized could be degradative ectoenzymes, auto-receptors or transport molecules (e.g. choline transporter). Alternatively they could be specific surface recognition molecules that have some role in the clustering of specific receptors to the post-synaptic site.
The simplest explanation would be that the antibodies recognize outwardly facing membranebound forms of the enzymes to which they were originally raised. Data supporting this possibility exist. Plasma membranes prepared from lysed rat brain synaptosomes and neuronal cell lines exhibit ChAT [ 17, 181 and GAD [ 191 activity even after salt washes which are designed to remove ionically bound enzymes. It is possible that this activity is due to the presence of soluble forms of the enzymes trapped in resealed membrane compartments. However, little, if any, LDH activity is present in these membrane preparations, indicating negligible cytoplasmic contamination. In addition, membrane solubilization and subsequent phase-separation in Triton X-114 reveals that a proportion of the membrane ChAT and GAD activity separates into the detergent-rich fraction (DRF). This suggests that these forms of the enzymes are definitely membrane-bound and may even be integral membrane proteins. It is also possible, however, that the enzyme activities retrieved are strongly associated with true membrane proteins, which may be integral, and it is these proteins that contain Triton-X-1 1Cbinding sites. Additional evidence for the intimate association of ChAT activity with the cholinergic cell-surface marker is provided by an examination of the cholinergic cell-line NS-20Y.
Here the presence of a membrane-bound form of ChAT can be directly correlated with a susceptibility to lysis [ 181. Undifferentiated cells do not lyse when exposed to anti-ChAT in the presence of complement, and their membranes contain very low levels of Triton-X-1 14-bound ChAT (0.03%).
Differentiated cells, however, do lyse when incubated in the same way, and 25% of their membranebound ChAT binds to Triton X-114. These results suggest that membrane-bound Triton X-114-extractable enzymically active ChAT is the cholinergic cell-surface marker rather than some other cross-reactive but otherwise unrelated cell-surface molecule.
Recently, an investigation of the membrane proteins recognized by anti-ChAT has been undertaken. When thoroughly washed synaptic plasma membranes (SPMs) prepared from rat cerebral cortex are subjected to Western blotting with antiChAT, two immunoreactive proteins with M, of 68 and 120 kDa are revealed. When the same SPMs are pretreated with Triton X-114 and phaseseparated into deterge-nt-poor (DPF) and detergentrich (DRF) fractions prior to Western blotting, the 68 kDa protein is seen only in the DPF, while the 120 kDa protein s found only in the DRF (i.e. it binds Triton X-114). It is tempting to speculate that this 120 kDa protein is the molecule which is present in membranes of cholinergic nerve terminals. Affinity purification of antibodies in the antiChAT sera prior to testing reveals that it is those which recognize the 120 kDa protein that are responsible for the antibody-dependent complement-mediated lysis and immunoaffinity purification of cholinergic synaptosomes.
Is the 120 kDa a membrane-bound form of cytoplasmic ChAT? Several observations suggest that it is different. A commercially available antibody to ChAT (Boerhinger-Mannheim Ltd) recognizes the 68 kDa protein but fails to recognize the 120 kDa protein in Western blots of rat brain SPMs. Also, when the monoclonal antibody to ChAT is incubated with synaptosomes prepared from rat cerebral cortex, and the labelled synaptosomes are subsequently exposed to complement, cholinergic terminals contained in the preparation are not lysed. A secondary polyclonal anti-immunoglobulin still does not induce lysis. Similarly, the monoclonal was ineffective as an affinity purification agent. The monoclonal anti-ChAT has been used on many occasions to identify cholinergic pathways in which it presumably recognizes cytoplasmic ChAT. Thus it seems likely that the monoclonal recognizes an epitope not present, or perhaps not exposed, in the 120 kDa protein. Most attempts to immunoprecipitate membrane-bound ChAT activity (after solubilization in Triton X-114) with antibodies recognizing the 120 kDa peptide, and subsequent exposure to either Pansorbin (Calbiochem) or anti-rabbit IgG Dynabeads M-450 (Dynal) at 4"C, have been unsuccessful. Western blotting with the original anti-ChAT reveals only the presence of the 120 kDa protein and not the 68 kDa protein in the immunoprecipitates. As no ChAT activity is present in these precipitates this suggests that the 120 kDa protein is incapable of acetylating choline. However, in some preparations up to 25% of the activity has been removed from solution when incubations are performed under more gentle solubilization conditions. When these immunoprecipitates are examined by Western blotting both the 68 kDa and 120 kDa proteins are always found to be present. This suggests that membrane-bound ChAT activity when present in Triton X-114 extracts is due to the presence of a 68 kDa protein which can be recognized by a monoclonal antibody produced to ChAT. In addition, the results suggest that the 120 kDa protein is the cholinergic cellsurface marker which may, under certain conditions, associate with a membrane form of ChAT. Solubilization in SDS before PAGE presumably always breaks this association.
It is tempting to speculate that the 120 kDa protein is the sodium-dependent high-affinity choline transporter long thought to be capable of forming a complex with ChAT. The fact that the original ChAT antiserum acting in the absence of complemeht is capable of inhibiting choline uptake is evidence that these antibodies recognize the transporter [ 91. Anti-ChAT cross-reactivity could be easily explained as both ChAT and the choline transporter have choline-binding sites.
An attempt is being made to purify the 120 kDa molecule in sufficient quantity from pig brain to enable sequencing to be undertaken. SPMs are A similar molecular and cell biological analysis of the GABAergic, dopaminergic, noradrenergic and serotonergic cell-surface molecules should show if they are neurotransmitter transporters or perhaps some other type of molecule which is related to the cholinergic NRP. Such analyses may show that these molecules belong to a novel family of neuronal cell-surface markers which are important perhaps in maintaining and stabilizing synapses of a particular chemical specificity.
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